KIT and gastrointestinal stromal tumor: Interestingly, pKit[Tyr721] was greatly reduced in BFA-treated GIST-T1, thus Kit could not activate the PI3K–Akt pathway, STAT5, or Erk (Figure 5a, right panels; see also Figure 5e, left panels).